Content area
Full Text
In a case series, 1 patient developed tardive dyskinesia during co-administration of aripiprazole and fluoxetine, while, the 2nd patient developed covert dyskinesia after aripiprazole withdrawal [routes not stated].
A 19-year-old man, who was primarily diagnosed with psychosis, started receiving treatment with aripiprazole tablet at a dose of 10mg which was titrated to 20mg in 2 weeks. He showed symptoms of akathisia and subsequently received treatment with trihexyphenidyl [trihexiphenidyl]. His psychotic illness continued for more than a month. Hence, fluoxetine capsule was started at a dose of 40mg which was increased to 60mg....